These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31268606)

  • 1. RASSF1A controls tissue stiffness and cancer stem-like cells in lung adenocarcinoma.
    Pankova D; Jiang Y; Chatzifrangkeskou M; Vendrell I; Buzzelli J; Ryan A; Brown C; O'Neill E
    EMBO J; 2019 Jul; 38(13):e100532. PubMed ID: 31268606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear Translocation.
    Pefani DE; Pankova D; Abraham AG; Grawenda AM; Vlahov N; Scrace S; O' Neill E
    Mol Cell; 2016 Jul; 63(1):156-66. PubMed ID: 27292796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway.
    Dubois F; Keller M; Calvayrac O; Soncin F; Hoa L; Hergovich A; Parrini MC; Mazières J; Vaisse-Lesteven M; Camonis J; Levallet G; Zalcman G
    Cancer Res; 2016 Mar; 76(6):1627-40. PubMed ID: 26759237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition.
    Xiong G; Deng L; Zhu J; Rychahou PG; Xu R
    BMC Cancer; 2014 Jan; 14():1. PubMed ID: 24383403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer.
    Lu T; Li Z; Yang Y; Ji W; Yu Y; Niu X; Zeng Q; Xia W; Lu S
    Cancer Lett; 2018 Jun; 423():36-46. PubMed ID: 29452146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma.
    Ooki A; Dinalankara W; Marchionni L; Tsay JJ; Goparaju C; Maleki Z; Rom WN; Pass HI; Hoque MO
    Oncogene; 2018 Nov; 37(45):5967-5981. PubMed ID: 29980786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of prolyl 4-hydroxylase subunit alpha-2 in lung adenocarcinoma indicates poor prognosis.
    Lu XH; Sang D; Zhang YR; Yuan Q
    Clinics (Sao Paulo); 2022; 77():100123. PubMed ID: 36403427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
    Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
    Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
    [No Abstract]   [Full Text] [Related]  

  • 9. NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells.
    Keller M; Dubois F; Teulier S; Martin APJ; Levallet J; Maille E; Brosseau S; Elie N; Hergovich A; Bergot E; Camonis J; Zalcman G; Levallet G
    J Exp Clin Cancer Res; 2019 Apr; 38(1):158. PubMed ID: 30979377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of CD109 Promotes the Epithelial-to-Mesenchymal Transition and Stemness Properties of Lung Adenocarcinomas via Activation of the Hippo-YAP Signaling.
    Lee KY; Kuo TC; Chou CM; Hsu WJ; Lee WC; Dai JZ; Wu SM; Lin CW
    Cells; 2020 Dec; 10(1):. PubMed ID: 33375719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and epigenetic alterations of the EGFR and mutually independent association with BRCA1, MGMT, and RASSF1A methylations in Vietnamese lung adenocarcinomas.
    Nguyen QN; Vuong LD; Truong VL; Ta TV; Nguyen NT; Nguyen HP; Chu HH
    Pathol Res Pract; 2019 May; 215(5):885-892. PubMed ID: 30723053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer.
    Schaal CM; Bora-Singhal N; Kumar DM; Chellappan SP
    Mol Cancer; 2018 Oct; 17(1):149. PubMed ID: 30322398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ITIH5 mediates epigenetic reprogramming of breast cancer cells.
    Rose M; Kloten V; Noetzel E; Gola L; Ehling J; Heide T; Meurer SK; Gaiko-Shcherbak A; Sechi AS; Huth S; Weiskirchen R; Klaas O; Antonopoulos W; Lin Q; Wagner W; Veeck J; Gremse F; Steitz J; Knüchel R; Dahl E
    Mol Cancer; 2017 Feb; 16(1):44. PubMed ID: 28231808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73.
    Papaspyropoulos A; Bradley L; Thapa A; Leung CY; Toskas K; Koennig D; Pefani DE; Raso C; Grou C; Hamilton G; Vlahov N; Grawenda A; Haider S; Chauhan J; Buti L; Kanapin A; Lu X; Buffa F; Dianov G; von Kriegsheim A; Matallanas D; Samsonova A; Zernicka-Goetz M; O'Neill E
    Nat Commun; 2018 Jan; 9(1):424. PubMed ID: 29382819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer.
    Wang Y; Yu Z; Wang T; Zhang J; Hong L; Chen L
    Lung Cancer; 2007 May; 56(2):289-94. PubMed ID: 17267069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression.
    Hsu YL; Hung JY; Chou SH; Huang MS; Tsai MJ; Lin YS; Chiang SY; Ho YW; Wu CY; Kuo PL
    Oncogene; 2015 Jul; 34(31):4056-68. PubMed ID: 25381822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression.
    Wu JE; Wu YY; Tung CH; Tsai YT; Chen HY; Chen YL; Hong TM
    Theranostics; 2020; 10(19):8903-8923. PubMed ID: 32754286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Meta-analysis of the Association between RASSF1A Gene Promoter Methylation and Non-small Cell Lung Cancer].
    Wei H; Fang N; Guo L; Wu Z; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):443-50. PubMed ID: 26182870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma.
    Zhao J; Lu Y; Ren X; Bian T; Feng J; Sun H; Liu L; She B; Liu Y; Ke H
    BMC Cancer; 2024 Jun; 24(1):687. PubMed ID: 38840077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression.
    Palakurthy RK; Wajapeyee N; Santra MK; Gazin C; Lin L; Gobeil S; Green MR
    Mol Cell; 2009 Oct; 36(2):219-30. PubMed ID: 19854132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.